Patient or Guinea Pig? Dilemma of Clinical Trials
Clinical trials for Rebetron, Schering-Plough's treatment for hepatitis C, illustrate the ethical questions that arise in tests of experimental drugs, including what obligations the pharmaceutical companies have to the patients they recruit and what obligations those patients have to science, to future patients who may be helped by research and to the company that may profit from it; Gail Ogden, who is three months into the 48-week trial, is very unhappy that data on her viral load is being withheld from her and her doctor; photo (M)